Impact of ageadjusted ageadjusted ageadjusted Insulin-like Growth Factor I on major cardiovascular events after acute myocardial infarction

Assistance Publique-Hôpitaux de Paris (APHP), Diabetology Department, Pitié Salpétrière Hospital, Paris, France (O.B.); Sorbonne Universités, UPMC Univ Paris 06, France (O.B., Y.L.B., T.S.); INSERM, UMR S 1138, Centre de recherche des Cordeliers, Paris 06, France (O.B.); Assistance Publique-Hôpitaux de Paris (APHP), Trousseau Hospital, Paris, France (Y.L.B.); INSERM, UMR938, Plateforme de microdosages, Paris 06, France (Y.L.B., N.B.); Centre hospitalier St JosephSt Luc, Lyon, France (B.R.); Hôpital Arnaud de Villeneuve, Montpellier, France (F.L.); Centre hospitalier Jacques Coeur, Bourges, France (X.T.); Assistance Publique-Hôpitaux de Paris (APHP), URCEST, St Antoine Hospital, Paris, France (L.B., S.K., E.D., T.S.); Société Française de Cardiologie (G.M.); Assistance Publique-Hôpitaux de Paris (APHP), HEGP, cardiology department, Paris, France (N.D.); Université René-Descartes, Paris05 (N.D.)